A Trial Comparing the Incidence of Hypophosphatemia in Relation to Treatment With Iron Isomaltoside and Ferric Carboxymaltose in Subjects With Iron Deficiency Anaemia Due to Inflammatory Bowel Disease
Clinical trial NCT03466983 · COMPLETED
Trial details
- NCT number
- NCT03466983
- Sponsor
- Pharmacosmos A/S
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2018-05-23
- Primary completion
- 2020-05-25
- Enrollment
- 97
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.